Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population

References

• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Bazarbashi S, DeVol E, Young S, Al-Eid H, Arteh S. Cancer Incidence Report Saudi Arabia 1999 – 2000. National Cancer Registry, Riyadh 2004
   Google Scholar
• Staudt L M. Gene expression profiling of lymphoid malignancies. Annu Rev Med 2002; 53: 303–318
   PubMed Web of Science ®Google Scholar
• Hegde U, Wilson W H. Gene expression profiling of lymphomas. Curr Oncol Rep 2001; 3: 243–249
   PubMedGoogle Scholar
• Alexander D D, Mink P J, Adami H O, Chang E T, Cole P, Mandel J S, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 12: 1–39, Review
   Web of Science ®Google Scholar
• Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M. Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 2002; 100: 3832–3834
   PubMed Web of Science ®Google Scholar
• Sekine I, Saijo N. Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Ann Oncol 2001; 12: 1515–1525
   PubMed Web of Science ®Google Scholar
• Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgRIIIa gene. Blood 2002; 99: 754–758
   PubMed Web of Science ®Google Scholar
• Park D J, Stoehlmacher J, Zhang W, Tsao-Wei D D, Groshen S, Lenz H J. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001; 61: 8654–8658
   PubMed Web of Science ®Google Scholar
• Relling M V, Dervieux T. Pharmacogenetics and cancer therapy. Nat Rev Cancer 1996; 1: 99–108
   Web of Science ®Google Scholar
• Nebert D W, McKinnon R A, Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 1996; 15: 273–280
   PubMed Web of Science ®Google Scholar
• Perera F P. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996; 88: 496–509
   PubMed Web of Science ®Google Scholar
• Sarmanova J, Benesova K, Gut I, Nedelcheva-Kristensen V, Tynkova L, Soucek P. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 2001; 10: 1265–1273
   PubMed Web of Science ®Google Scholar
• Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 2002; 118: 477–481
   PubMed Web of Science ®Google Scholar
• Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 2006; 81: 62–70
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Mukda E, Sasanakul W, Kadegasem P, Udomsubpayakul U, Thithapandha A, et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005; 79: 202–205
   PubMed Web of Science ®Google Scholar
• Kelada S N, Stapleton P L, Farin F M, Bammler T K, Eaton D L, Smith-Weller T, et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett 2003; 337: 5–8
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene – gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000; 9: 557–562
   PubMed Web of Science ®Google Scholar
• Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukemia. Carcinogenesis 2000; 21: 43–47
   PubMed Web of Science ®Google Scholar
• Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 2002; 99: 4216–4218
   PubMed Web of Science ®Google Scholar
• Hohaus S, Massini G, D'Alo' F, Guidi F, Putzulu R, Scardocci A, et al. Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis. Clin Cancer Res 2003; 9: 3435–3440
   PubMed Web of Science ®Google Scholar
• Venugopal R, Jaiswal A K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 1996; 93: 14960–14965
   PubMed Web of Science ®Google Scholar
• Larson R A, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau M M, et al. Prevalence of the inactivating 609C → T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999; 94: 803–807
   PubMed Web of Science ®Google Scholar
• Schulz W A, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, Ebert T, et al. Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997; 7: 235–239
   PubMedGoogle Scholar
• el-Hazmi M A, al-Swailem A R, Warsy A S, al-Swailem A M, Sulaimani R, al-Meshari A A. Consanguinity among the Saudi Arabian population. J Med Genet 1995; 32: 623–626
   PubMed Web of Science ®Google Scholar
• Bu R, Gutierrez M I, Al-Rasheed M, Belgaumi A, Bhatia K. Variable drug metabolism genes in Arab population. Pharmacogenomics J 2004; 4: 260–266
   PubMed Web of Science ®Google Scholar
• Garte S, Gaspari L, Alexandrie A K, Ambrosone C, Autrup H, Autrup J L, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239–1248
   PubMed Web of Science ®Google Scholar
• Robien K, Ulrich C M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 2003; 157: 571–582
   PubMed Web of Science ®Google Scholar
• Nebert D W, Roe A L, Vandale S E, Bingham E, Oakley G G. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 2002; 4: 62–70
   PubMed Web of Science ®Google Scholar
• Cosma G, Crofts F, Taioli E, Toniolo P, Garte S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 1993; 40: 309–316
   PubMed Web of Science ®Google Scholar
• Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 1996; 87: 18–24
   PubMedGoogle Scholar
• Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990; 263: 131–133
   PubMed Web of Science ®Google Scholar
• Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem (Tokyo) 1991; 110: 407–411
   PubMed Web of Science ®Google Scholar
• Vineis P, d'Errico A, Malats N, Boffetta P. Metabolic Polymorphisms and Susceptibility to Cancer. IARC, Lyon 1999, IARC Scientific Publications 148
   Google Scholar
• Kiss I, Sandor J, Pajkos G, Bogner B, Hegedus G, Ember I. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res 2000; 20: 519–522
   PubMed Web of Science ®Google Scholar
• Sivaraman L, Leatham M P, Yee J, Wilkens L R, Lau A F, LeMarchand L. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 1994; 54: 3692–3695
   PubMed Web of Science ®Google Scholar
• Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 2000; 464: 65–76
   PubMed Web of Science ®Google Scholar
• Davies S M, Robison L L, Buckley J D, Tjoa T, Woods W G, Radloff G A, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 2001; 19: 1279–1287
   PubMed Web of Science ®Google Scholar
• Anderer G, Schrappe M, Brechlin A M, Lauten M, Muti P, Welte K, et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000; 10: 715–726
   PubMedGoogle Scholar
• Haase D, Binder C, Bunger J, Fonatsch C, Streubel B, Schnittger S, et al. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002; 26: 249–254
   PubMed Web of Science ®Google Scholar
• Rollinson S, Levene A P, Mensah F K, Roddam P L, Allan J M, Diss T C, et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 2003; 102: 1007–1011
   PubMed Web of Science ®Google Scholar
• Hayes J D, Pulford D J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445–600
   PubMed Web of Science ®Google Scholar
• Chiu B C, Kolar C, Gapstur S M, Lawson T, Anderson J R, Weisenburger D D. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study. Br J Haematol 2005; 128: 610–615
   PubMed Web of Science ®Google Scholar
• Ryberg D, Skaug V, Hewer A, Phillips D H, Harries L W, Wolf C R, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997; 18: 1285–1289
   PubMed Web of Science ®Google Scholar
• Park J Y, Schantz S P, Stern J C, Kaur T, Lazarus P. Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 1999; 9: 497–504
   PubMedGoogle Scholar
• Longuemaux S, Delomenie C, Gallou C, Mejean A, Vincent-Viry M, Bouvier R, et al. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999; 59: 2903–2908
   PubMed Web of Science ®Google Scholar
• Helzlsouer K J, Selmin O, Huang H Y, Strickland P T, Hoffman S, Alberg A J, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998; 90: 512–518
   PubMed Web of Science ®Google Scholar
• Toffoli G, Rossi D, Gaidano G, Cecchin E, Boiocchi M, Carbone A. Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase. Int J Biol Markers 2003; 18: 218–221
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Taji H, et al. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 2004; 77: 351–357
   PubMed Web of Science ®Google Scholar
• Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574–3581
   PubMed Web of Science ®Google Scholar